Drawing for MAKE WELL KNOWN.

USPTO serial 86036380

MAKE WELL KNOWN.

Reviewed by CopyMark Law Group

Reg. 4501468Status 800Registered
Filing date
Status date
Registration date
Mar 25, 2014
Examiner
LAMOTHE, LESLEY
Law office
GENERIC WEB UPDATE

What this means

Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with MAKE WELL KNOWN.?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Patricia Lawrence-Kolaras, Esq.

Patricia Lawrence-Kolaras, Esq. The PLK Law Group, P.C.284 U.S. Route 206, Building E, Suite 10HILLSBOROUGH, NJ 08844UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Advertising and business management consultancy; Advertising and marketing consultancy; Advertising and promotion services and related consulting; Advertising consultation; Advertising relating to pharmaceutical products and in-vivo imaging products; Brand imagery consulting services; Branding services, namely, consulting, development, management and marketing of brands for businesses and/or individuals; Business advisory services, consultancy and information; Business and management consulting for healthcare providers and related businesses; Business assistance, advisory and consulting services in the field of pharmaceuticals; Business consultancy; Business consultation; Business consultation and management regarding marketing activities and launching of new products; Business consultation in the field of biotechnology; Business consultation services; Business consultation services in the fields of supply chain analysis, regulation compliance and counterfeit detection; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, providing information management services; Business consulting in the consumer products industry; Business consulting services in the field of healthcare marketing; Business consulting services, namely, providing assistance in development of business strategies and creative ideation; Business management and consultation; Business management and consultation in the field of healthcare; Business management and consulting services for the health care industry, namely, providing industry expertise and supplier partnerships; Business management consultancy and advisory services; Business management consultancy as well as development of processes for the analysis and the implementation of strategy plans and management projects; Business management consultancy services; Business management consultation; Business management consulting; Business management consulting and advisory services; Business management consulting and advisory services for the pharmaceutical industry; Business management consulting, strategic planning and business advisory services provided to physicians; Business marketing consulting services; Business monitoring and consulting services, namely, tracking web sites and applications of others to provide strategy, insight, marketing, sales, operation, product design, particularly specializing in the use of analytic and statistic models for the understanding and predicting of consumers, businesses, and market trends and actions; Business organisation and management consulting services; Business organization and management consulting; Business organization and operation consultancy; Business research consultation; Business services, namely, consumer research and consulting related thereto; Business services, namely, structuring, optimizing and change management consulting related to corporate in-house intellectual property departments and intellectual property asset management programs; Consultancy and advisory services in the field of business strategy; Consultancy services regarding business strategies; Consultation services in the field of company, business sector and industry data and research; Consultation services, namely, creative and strategic consultation regarding development and production of marketing campaigns for others; Consulting in the field of sales methods, sales management, and sales improvement; Consulting in the fields of healthcare operations management and hospital operations management; Consulting regarding intellectual property business risk mitigation processes; Consulting services in the cost and payment management of health care; Consulting services in the field of managing intellectual properties; Consulting services in the field of medical product approval for commercial purposes; Consulting services in the field of patient relationship management for healthcare providers; Consulting services, namely, to employers, community organizations, brokers and beneficiaries, related to consumer information regarding health care plan options, products and programs in the field of managed care and state and federal medical care programs; Consumer marketing research and consulting related thereto; Management consulting and advisory services in the areas of corporate growth strategy, innovation and growth processes, organizational transformation, and talent management and development strategies; Market research consultation; Market segmentation consultation; Marketing consultation in the field of pharmaceuticals; Marketing consulting; Pharmaceutical cost management services and drug utilization review services; Professional business consultation; Professional business consulting; Providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences; Providing business management information in connection with consulting and advisory services in the field of strategic planning; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approvalACTIVEAug 1, 2013

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 9, 2024NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Mar 9, 2024RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Mar 9, 202489AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Mar 9, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 27, 2023E89RTEAS SECTION 8 & 9 RECEIVED—
Mar 25, 2023REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Mar 16, 2020NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Mar 16, 20208.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Mar 12, 2020EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Apr 17, 2019PRA8POST REGISTRATION ACTION MAILED - SEC. 8—
Apr 17, 2019APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 15, 2019ES8RTEAS SECTION 8 RECEIVED—
Mar 25, 2019REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Mar 25, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 7, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 7, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 18, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 4, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 29, 2013DOCKASSIGNED TO EXAMINER—
Aug 21, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 16, 2013NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance